Who is sponsoring NCT03442231?

NCT03442231 is sponsored by Smith & Nephew, Inc..

What drugs are being tested in NCT03442231?

Interventions in NCT03442231: Journey UNI Unicompartmental Knee System.

What condition does NCT03442231 study?

NCT03442231 studies Non-inflammatory Degenerative Joint Disease.

Is NCT03442231 still recruiting?

NCT03442231 is currently status unknown. Last updated 20 February 2024.

Last reviewed 2024-02-20 · How we verify

NCT03442231: Journey UNI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Journey™ UNI Post Market Clinical Follow-Up

Status unknown Last updated 20 February 2024

What this trial tests

trial testing Journey UNI Unicompartmental Knee System in Non-inflammatory Degenerative Joint Disease in 147 participants. Status unknown.

Timeline

11 April 2018

Primary endpoint
11 April 2025

11 April 2025

Quick facts

Lead sponsor	Smith & Nephew, Inc.
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	147
Start date	11 April 2018
Primary completion	11 April 2025
Estimated completion	11 April 2025
Sites	4 locations across Canada, United States

Drugs / interventions tested

Journey UNI Unicompartmental Knee System

Conditions studied

Non-inflammatory Degenerative Joint Disease — all drugs for Non-inflammatory Degenerative Joint Disease →

Sponsor

Smith & Nephew, Inc. — full company profile →

Who can join

18 and older, any sex, with Non-inflammatory Degenerative Joint Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a retrospective/prospective, open-label single cohort, multicenter study to collect relevant clinical data from 147 subjects with unicompartmental degeneration of the knee in whom the Journey UNI UKS was previously implanted.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Non-inflammatory Degenerative Joint Disease

Currently open trials in the same condition.

NCT03885622 — Safety and Efficacy of the ANTHEM™ CR Total Knee System · active not recruiting

Other Smith & Nephew, Inc. trials

Trials by the same sponsor.

NCT07025304 — Post-Market Clinical Study to Evaluate the Safety and Effectiveness of REFLEX ULTRA 45 for Coblation Inferior Turbinate · NA · recruiting
NCT06916728 — A Post Approval Multicenter 10 Year Follow-up Observational Trial of Marketed Product - MP01 vs. Surgical Standard of Ca · enrolling by invitation
NCT06831448 — Human Participant Study of a Prototype Multilayer Foam Dressing on Intact Skin. · NA · completed
NCT06700850 — Human Participant Study of Prototype Non-medicated Multilayer Foam Dressings on Intact Skin · NA · completed
NCT06306716 — A Clinical Study on New Negative Pressure Wound Therapy Dressing in the Management of Chronic & Acute Wounds · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03442231 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Smith & Nephew, Inc.
Last refreshed: 20 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03442231.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing